BAYN — Bayer AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapValue Trap

Annual income statement for Bayer AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	43,545	41,400	44,081	50,739	47,637
Cost of Revenue
Gross Profit	25,932	22,262	27,265	30,868	27,888
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	39,383	57,569	40,728	43,727	47,025
Operating Profit	4,162	-16,169	3,353	7,012	612
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,853	-17,250	2,046	4,670	-1,621
Provision for Income Taxes
Net Income After Taxes	2,410	-15,561	1,022	4,166	-2,942
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	4,091	-10,495	1,000	4,150	-2,941
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,091	-10,495	1,000	4,150	-2,941
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.33	-1.25	4.39	8.12	6.41
Dividends per Share